SCHEMBL5438415

SCHEMBL5438415

COc1cccc(-c2nc3c(=O)[nH]c(=O)n(C)c3nc2O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
SERPINE1 P05121 1/20 0.43
KDM5B Q9UGL1 1/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5435686 0.87 XDH (0.45) XDHL3MBTL1PDE3BPDE3AKDM5B
SCHEMBL5448031 0.86 KDM4E (0.47) XDHPDE3BPDE3AHPGDMEN1
SCHEMBL5443099 0.84 PGR (0.45) XDHKDM5BMEN1KMT2ANPSR1
SCHEMBL5442836 0.83 TP53 (0.44) L3MBTL1HPGDHTTKMT2ANPSR1
SCHEMBL6050843 0.83 PDE4A (0.42) HPGDKMT2AMAPTSMN1; SMN2
SCHEMBL5443111 0.81 EPHB4 (0.41) KMT2AGAAMAPTSMN1; SMN2
SCHEMBL5443537 0.77 ALDH1A1 (0.44) HPGDMEN1KMT2ALMNAMAPT
SCHEMBL5446598 0.76 BRDT (0.41) KMT2ASMN1; SMN2
SCHEMBL5446767 0.76 KMT2A (0.45) HPGDMEN1HTTKMT2ALMNA
SCHEMBL5449103 0.74 KDM4E (0.41) KDM5BHPGDMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043000-A1 Immunosuppresive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2007-02-22 US disclosed
EP-1636232-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA Bioscience nv (BE) 2006-03-22 EP disclosed
WO-2004104005-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA BIOSCIENCE NV (BE) 2004-12-02 WO disclosed
EP-1479682-A1 Immunosuppressive effects of pteridine derivatives 4 AZA Bioscience nv (BE) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043000-A1 Immunosuppresive effects of pteridine derivatives TPMT, FKBP5, RRP15 XDH 1819/4885L3MBTL1 749/4885PDE3B 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.